Shida Shangguan

Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial

Trevor A. Crowell, Donn Colby, Suteeraporn Pinyakorn et al. · The Lancet HIV · 2019 · 98 citations · Full text

Treatment And Prevention, Immunotherapy, Human Retrovirus +7

A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials

Philip K. Ehrenberg, Shida Shangguan, Biju Issac et al. · Science Translational Medicine · 2019 · 32 citations · Full text

Vaccination, Primary Immunodeficiency, Composite Gene Expression +14

Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1

Shida Shangguan, Philip K. Ehrenberg, Aviva Geretz et al. · eLife · 2021 · 28 citations · Full text

Antibody-dependent Cellular Phagocytosis, Monocyte-derived Transcriptome Signature, Gene Signature +18

Single-cell transcriptomics identifies prothymosin α restriction of HIV-1 in vivo

Aviva Geretz, Philip K. Ehrenberg, Robert Clifford et al. · Science Translational Medicine · 2023 · 23 citations · Full text

HLA-B∗46 associates with rapid HIV disease progression in Asian cohorts and prominent differences in NK cell phenotype

Shuying S. Li, Andrew C. Hickey, Shida Shangguan et al. · Cell Host & Microbe · 2022 · 19 citations · Full text